Fox Chase researchers win $1.4M DoD Prostate Cancer Health Equity Grant

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

A team of researchers at Fox Chase Cancer Center was awarded a Department of Defense Prostate Cancer Health Disparity Research Award for New Investigators.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe

YOU MAY BE INTERESTED IN

The tremendous promise—and potential peril—of the prostate-specific antigen (PSA) screening test have confounded guideline developers for decades. When introduced, PSA was one of the first and the only credible blood biomarkers for cancer screening. That a simple blood test should be used to screen for the most common cancer in men, one that was lethal for 3% of men and 5% of Black men, seemed like a slam dunk. 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login